Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Riggs

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|January 1, 1997
Population pharmacokinetics/pharmacodynamics and individualized drug therapyM M Riggs
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Predicting nonlinear changes in bone mineral density over time using a multiscale systems pharmacology modelM C Peterson, M M Riggs
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment?M C Peterson, M M Riggs
CPT: Pharmacometrics & Systems Pharmacology|October 10, 2015
Connecting the Dots: Linking Osteocyte Activity and Therapeutic Modulation of Sclerostin by Extending a Multiscale Systems ModelR J Eudy, M R Gastonguay, K T Baron, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
Integrated pharmacometrics and systems pharmacology model-based analyses to guide GnRH receptor modulator development for management of endometriosisM M Riggs, M Bennetts, P H van der Graaf, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|January 1, 1997
Population pharmacokinetics/pharmacodynamics and individualized drug therapyM M Riggs
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Predicting nonlinear changes in bone mineral density over time using a multiscale systems pharmacology modelM C Peterson, M M Riggs
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment?M C Peterson, M M Riggs
CPT: Pharmacometrics & Systems Pharmacology|October 10, 2015
Connecting the Dots: Linking Osteocyte Activity and Therapeutic Modulation of Sclerostin by Extending a Multiscale Systems ModelR J Eudy, M R Gastonguay, K T Baron, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
Integrated pharmacometrics and systems pharmacology model-based analyses to guide GnRH receptor modulator development for management of endometriosisM M Riggs, M Bennetts, P H van der Graaf, et al.
Pageof 1